Latest filing published 25 Jun 2026 for 皓元医药, €93k.
Filing timeline
BuySaleInsider track record
李硕梁: trading record in brief
All filings by 李硕梁 on record concern 皓元医药. In total, 4 filings cover trades dated from 10 December 2025 to 25 June 2026.
On the market, this insider has only sold: 4 sales, €477k in total. In 2026 alone, the filings show no purchases and 2 sales.
The newest entry dates from 25 June 2026: an open-market sale of €93k, in 皓元医药. Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Companies and markets linked to 李硕梁
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,812 shares@ CN¥711.332319.6% of flowA股XSHGSSE:273000000765915940
- 9,588 shares@ CN¥711.672224.1% of flowA股XSHGSSE:273000000761621250
- 22,000 shares41.5% of flowA股XSHGSSE:273000000018963740
- 8,000 shares14.8% of flowA股XSHGSSE:273000000016265150
4 of 4 declarations